Trending Stock News

Fulgent Genetics, Inc. (FLGT) Analysts See $-0.03 EPS; Amrep New (AXR) Shorts Down By 4.72%

Amrep Corporation New (NYSE:AXR) had a decrease of 4.72% in short interest. AXR’s SI was 22,200 shares in February as released by FINRA. Its down 4.72% from 23,300 shares previously. With 2,700 avg volume, 8 days are for Amrep Corporation New (NYSE:AXR)’s short sellers to cover AXR’s short positions. The SI to Amrep Corporation New’s float is 0.67%. The stock increased 0.26% or $0.02 during the last trading session, reaching $7.52. About 1,111 shares traded. AMREP Corporation (NYSE:AXR) has risen 41.57% since February 16, 2017 and is uptrending. It has outperformed by 24.87% the S&P500.

Analysts expect Fulgent Genetics, Inc. (NASDAQ:FLGT) to report $-0.03 EPS on February, 26.They anticipate $0.08 EPS change or 160.00% from last quarter’s $0.05 EPS. After having $-0.05 EPS previously, Fulgent Genetics, Inc.’s analysts see -40.00% EPS growth. The stock decreased 0.21% or $0.01 during the last trading session, reaching $4.7. About 5,611 shares traded. Fulgent Genetics, Inc. (NASDAQ:FLGT) has 0.00% since February 16, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 2 analysts covering Fulgent Genetics (NASDAQ:FLGT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Fulgent Genetics had 2 analyst reports since October 24, 2016 according to SRatingsIntel. The rating was initiated by Piper Jaffray on Monday, October 24 with “Overweight”. Credit Suisse initiated Fulgent Genetics, Inc. (NASDAQ:FLGT) rating on Monday, October 24. Credit Suisse has “Outperform” rating and $13 target.

Fulgent Genetics, Inc., a technology company, focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. The company has market cap of $83.77 million. The company's technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. It currently has negative earnings. It primarily serves hospitals and medical institutions.

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It has no change, as 2 investors sold AMREP Corporation shares while 4 reduced holdings. only 1 funds opened positions while 4 raised stakes. 1.67 million shares or 2.43% less from 1.72 million shares in 2017Q2 were reported. Robotti Robert reported 707,019 shares. Arbiter Partners Mngmt Limited Company has 113,095 shares for 0.09% of their portfolio. Wells Fargo & Communications Mn holds 1 shares or 0% of its portfolio. Weber Alan W stated it has 0.47% in AMREP Corporation (NYSE:AXR). Blackrock reported 0% in AMREP Corporation (NYSE:AXR). Morgan Stanley holds 0% or 27 shares in its portfolio. Texas-based Bridgeway Cap Mngmt Incorporated has invested 0.01% in AMREP Corporation (NYSE:AXR). Nationwide Fund Advsrs has 216 shares. 62,477 were reported by Hightower Advsrs Ltd Company. Moreover, Oppenheimer Close Lc has 0.34% invested in AMREP Corporation (NYSE:AXR) for 49,032 shares. Tower Research Capital Ltd (Trc) reported 0% stake. Vanguard Gru holds 51,083 shares. Royal Retail Bank Of Canada reported 8,101 shares. Dimensional Fund Advsr L P has invested 0% of its portfolio in AMREP Corporation (NYSE:AXR). Perritt Cap Management stated it has 0.12% in AMREP Corporation (NYSE:AXR).

Leave a Reply

Your email address will not be published. Required fields are marked *